Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-24 9:31 pm Purchase | 2026-04-20 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 12,717,487 9.900% | 24,646 (+0.19%) | Filing History |
| 2026-04-24 9:28 pm Purchase | 2026-04-20 | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group, LLC | 10,696,314 9.900% | 3,726,007 (+53.46%) | Filing History |
| 2026-04-22 9:47 pm Purchase | 2026-04-20 | 13D | FATE THERAPEUTICS INC FATE | Redmile Group, LLC | 18,229,078 14.900% | 287,499 (+1.60%) | Filing History |
| 2026-04-14 9:00 pm Sale | 2026-04-10 | 13D | ABSCI CORP ABSI | Redmile Group, LLC | 7,607,449 4.900% | -645,867 (-7.83%) | Filing History |
| 2026-04-06 9:47 pm Sale | 2026-04-06 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 12,692,841 9.900% | -2,973,890 (-18.98%) | Filing History |
| 2026-03-26 5:00 pm Sale | 2026-03-24 | 13D | ABSCI CORP ABSI | Redmile Group, LLC | 8,253,316 5.400% | -81,800 (-0.98%) | Filing History |
| 2026-02-17 4:16 pm Purchase | 2025-12-31 | 13G | NEUROGENE INC NGNE | Redmile Group, LLC | 1,557,179 9.900% | 77,413 (+5.23%) | Filing History |
| 2026-02-17 4:15 pm Purchase | 2025-12-31 | 13G | IMMUNOME INC IMNM | Redmile Group, LLC | 5,718,385 5.200% | 357,198 (+6.66%) | Filing History |
| 2026-02-17 4:15 pm Purchase | 2025-12-31 | 13G | ANNEXON INC ANNX | Redmile Group, LLC | 15,427,866 9.900% | 7,344,090 (+90.85%) | Filing History |
| 2026-02-17 4:15 pm Unchanged | 2025-12-31 | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group, LLC | 15,666,731 12.700% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:19 pm Purchase | 2025-11-12 | 13D | ATARA BIOTHERAPEUTICS INC ATRA | Redmile Group, LLC | 751,223 9.900% | 46,016 (+6.53%) | Filing History |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | ZYMEWORKS INC ZYME | Redmile Group, LLC | 3,705,750 4.900% | -444,877 (-10.72%) | Filing History |
| 2025-11-14 4:15 pm Sale | 2025-09-30 | 13G | REPLIMUNE GROUP INC REPL | Redmile Group, LLC | 535,818 0.700% | -4,362,709 (-89.06%) | Filing History |
| 2025-08-26 5:01 pm Purchase | 2025-08-25 | 13D | SHATTUCK LABS INC STTK | Redmile Group, LLC | 6,379,095 9.900% | 726,435 (+12.85%) | Filing History |
| 2025-08-15 5:01 pm Sale | 2025-08-14 | 13D | IGM BIOSCIENCES INC IGMS | Redmile Group, LLC | 0 0.000% | -3,291,092 (Position Closed) | Filing History |
| 2025-08-14 4:20 pm Sale | 2025-06-30 | 13G | ZYMEWORKS INC ZYME | Redmile Group, LLC | 4,150,627 5.600% | -689,836 (-14.25%) | Filing History |
| 2025-08-14 4:19 pm Sale | 2025-06-30 | 13G | STOKE THERAPEUTICS INC STOK | Redmile Group, LLC | 4,375,931 8.000% | -337,578 (-7.16%) | Filing History |
| 2025-08-14 4:18 pm Purchase | 2025-06-30 | 13G | REGENXBIO INC RGNX | Redmile Group, LLC | 5,062,477 9.900% | 120,165 (+2.43%) | Filing History |
| 2025-08-14 4:18 pm Purchase | 2025-06-30 | 13G | RAPT THERAPEUTICS INC RAPT | Redmile Group, LLC | 1,765,303 9.900% | 23,747 (+1.36%) | Filing History |
| 2025-08-14 4:17 pm Sale | 2025-06-30 | 13G | ALX ONCOLOGY HLDGS INC ALXO | Redmile Group, LLC | 4,641,455 8.500% | -267,809 (-5.46%) | Filing History |